A Study of the Effects of Fish Protein Intake on Glucose Regulation in Overweight and Obese Adults.
- Conditions
- ObesityOverweight
- Registration Number
- NCT01641055
- Lead Sponsor
- University of Bergen
- Brief Summary
The purpose of this study is to compare the possible health benefits of intake of proteins from salmon, herring, cod and milk on glucose tolerance in overweight and obese adults. Overweight and obese subjects often have reduced glucose tolerance, and previous findings from a study on cod proteins suggested that glucose tolerance was improved.
- Detailed Description
Participants receive 2.5g protein per day for 8 weeks as tablets.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 93
- BMI above 27 kg/m2
- healthy
- fasting blood glucose above 7 mM
- medication that affects blood glucose, lipids and inflammatory status
- pregnancy or breastfeeding
- allergies to fish or milk
- intentional weight loss and large fluctuation in body weight
- a high consumption of fish
- an extreme diet
- use of fish oil, n-3 or multivitamin supplements
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method Glucose regulation 8 weeks Glucose will be measured in fasting and postprandial samples
- Secondary Outcome Measures
Name Time Method Changes in serum insulin, insulin C-peptide, non-esterified fatty acids, lipids, adiponectin, leptin and fatty acid composition 8 weeks Changes in serum concentrations of vitamins 8 weeks Comparisons of metabolites and co-factors involved in one-carbon metabolism in serum and urine 8 weeks Concentrations of relevant metabolites and co-factors were measured in serum and urine
Changes in serum and urine concentrations of amino acids and their metabolites 8 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Institute of Medicine, University of Bergen
🇳🇴Bergen, Norway
Institute of Medicine, University of Bergen🇳🇴Bergen, Norway